The next generation of cardiac positron emission tomography imaging agents: Discovery of flurpiridaz F-18 for detection of coronary disease

Seminars in Nuclear Medicine

Volumn 41, Issue 4, 2011, Pages 305-313

  Yu, Ming ^a   Nekolla, Stephan G ^b   Schwaiger, Markus ^b   Robinson, Simon P ^a  

^a A Subsidiary of Lantheus Holdings   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA N 13; FLURPIRIDAZ F 18; IODOROTENONE I 125; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXYGEN 15; RADIOPHARMACEUTICAL AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RUBIDIUM 82; TETROFOSMIN TC 99M; UNCLASSIFIED DRUG;

CARDIAC IMAGING; CORONARY ARTERY DISEASE; DOSIMETRY; DRUG HALF LIFE; DRUG SAFETY; DRUG TARGETING; DRUG UPTAKE; HEART MUSCLE BLOOD FLOW; HUMAN; IMAGE QUALITY; LIVER SCINTISCANNING; LUNG SCINTISCANNING; MYOCARDIAL PERFUSION IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW;

ANIMALS; CORONARY DISEASE; ELECTRON TRANSPORT COMPLEX I; HEART; HUMANS; MYOCARDIAL PERFUSION IMAGING; POSITRON-EMISSION TOMOGRAPHY; PRIMATES; PYRIDAZINES; RABBITS; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RATS; RISK ASSESSMENT; SWINE; TISSUE DISTRIBUTION;

EID: 79957677543     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2011.02.004     Document Type: Review

References (40)

1. Glover DK, Gropler RJ: Journey to find the ideal PET flow tracer for clinical use: are we there yet? J Nucl Cardiol 14:765-768, 2007 (Pubitemid 350082590)
2. Salerno M, Beller GA: Noninvasive assessment of myocardial perfusion. Circ Cardiovasc Imaging 2:412-424, 2009
3. Bateman TM, Heller GV, McGhie AI, et al: Diagnostic accuracy of rest/ stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 13:24-33, 2006 (Pubitemid 43192726)
4. Shaw LJ, Shaw RE, Merz CN, et al: Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 117:1787-1801, 2008 (Pubitemid 351507467)
5. Patel MR, Peterson ED, Dai D, et al: Low diagnostic yield of elective coronary angiography. N Engl J Med 362:886-895, 2010
6. Di Carli MF, Hachamovitch R: New technology for noninvasive evaluation of coronary artery disease. Circulation 115:1464-1480, 2007 (Pubitemid 46648384)
7. Garcia EV, Eisner RL, Patterson RE: What should we expect from cardiac PET? J Nucl Med 34:978-980, 1993
8. Beller GA, Bergmann SR: Myocardial perfusion imaging agents: SPECT and PET. J Nucl Cardiol 11:71-86, 2004 (Pubitemid 38219572)
9. Bengel FM, Higuchi T, Javadi MS, et al: Cardiac positron emission tomography. J Am Coll Cardiol 54:1-15, 2009
10. Heller GV, Calnon D, Dorbala S: Recent advances in cardiac PET and PET/CT myocardial perfusion imaging. J Nucl Cardiol 16:962-969, 2009
11. Piwnica-Worms D, Kronauge JF, Chiu ML: Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation 82:1826-1838, 1990
12. Younes A, Songadele JA, Maublant J, et al: Mechanism of uptake of technetium-tetrofosmin: II - uptake into isolated adult rat heart mitochondria. J Nucl Cardiol 2:327-333, 1995
13. Marshall RC, Powers-Risius P, Reutter BW, et al: Kinetic analysis of 125I-iodorotenone as a deposited myocardial flow tracer: comparison with 99mTc-sestamibi. J Nucl Med 42:272-281, 2001 (Pubitemid 32150518)
14. Lummen P: Complex I inhibitors as insecticides and acaricides. Biochim Biophys Acta 1364:287-296, 1998
15. Miyoshi H: Structure-activity relationships of some complex I inhibitors. Biochim Biophys Acta 1364:236-244, 1998
16. Hollingworth RM, Ahammadsahib KI, Gadelhak G, et al: New inhibitors of complex I of the mitochondrial electron transport chain with activity as pesticides. Biochem Soc Trans 22:230-233, 1994 (Pubitemid 24072425)
17. Lindell SD, Ort O, Lummen P, et al: The design and synthesis of novel inhibitors of NADH: ubiquinone oxidoreductase. Bioorg Med Chem Lett 14:511-514, 2004 (Pubitemid 38045156)
18. Okun JG, Lummen P, Brandt U: Three classes of inhibitors share a common binding domain in mitochondrial complex: I (NADH:ubiquinone oxidoreductase). J Biol Chem 274:2625-2630, 1999 (Pubitemid 29075339)
19. Purohit A, Benetti R, Hayes M, et al: Quinazoline derivatives as MC-I inhibitors: evaluation of myocardial uptake using positron emission tomography in rat and non-human primate. Bioorg Med Chem Lett 17:4882-4885, 2007 (Pubitemid 47187691)
20. Purohit A, Radeke H, Azure M, et al: Synthesis and biological evaluation of pyridazinone analogues as potential cardiac positron emission tomography tracers. J Med Chem 51:2954-2970, 2008 (Pubitemid 351706024)
21. Radeke H, Hanson K, Yalamanchili P, et al: Synthesis and biological evaluation of the mitochondrial complex 1 inhibitor 2-[4-(4-fluorobutyl) benzylsulfanyl]-3-methylchromene-4-one as a potential cardiac positron emission tomography tracer. J Med Chem 50:4304-4315, 2007 (Pubitemid 47378830)
22. Yu M, Guaraldi M, Kagan M, et al: Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates. Eur J Nucl Med Mol Imaging 36:63-72, 2009
23. Yalamanchili P, Wexler E, Hayes M, et al: Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. J Nucl Cardiol 14:782-788, 2007 (Pubitemid 350082573)
24. Yu M, Mistry M, Guaraldi M, et al: [18F]-RP1012: a novel myocardial perfusion imaging agent for use with positron emission tomography (PET). Circulation 112:II-761, 2005
25. Yu M, Guaraldi MT, Mistry M, et al: BMS-747158-02: a novel PET myocardial perfusion imaging agent. J Nucl Cardiol 14:789-798, 2007 (Pubitemid 350082572)
26. Huisman MC, Higuchi T, Reder S, et al: Initial characterization of an 18F-labeled myocardial perfusion tracer. J Nucl Med 49:630-636, 2008 (Pubitemid 351520612)
27. Higuchi T, Nekolla SG, Huisman MM, et al: A new 18F-labeled myocardial PET tracer: myocardial uptake after permanent and transient coronary occlusion in rats. J Nucl Med 49:1715-1722, 2008
28. Nekolla SG, Reder S, Saraste A, et al: Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 119:2333-2342, 2009
29. Sherif HM, Saraste A, Weidl E, et al: Evaluation of a novel 18F-labeled positron-emission tomography perfusion tracer for the assessment of myocardial infarct size in rats. Circ Cardiovasc Imaging 2:77-84, 2009
30. Maddahi J, Schiepers C, Czernin J, et al: First human study of BMS747158, a novel F-18 labeled tracer for myocardial perfusion imaging. J Nucl Med 49:70P, 2008
31. Leppo JA, Meerdink DJ: Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res 65:632-639, 1989 (Pubitemid 19226439)
32. Schelbert HR, Phelps ME, Huang SC, et al: N-13 ammonia as an indicator of myocardial blood flow. Circulation 63:1259-1272, 1981 (Pubitemid 11120661)
33. Mullani NA, Goldstein RA, Gould KL, et al: Myocardial perfusion with rubidium-82: I - measurement of extraction fraction and flow with external detectors. J Nucl Med 24:898-906, 1983 (Pubitemid 14236772)
34. Sherif HM, Nekolla SG, Saraste A, et al: Simplified quantification of myocardial blood flow with 18F BMS-747158-02: comparison to kinetic modeling and microspheres in a pig model. J Nucl Med 51:73P, 2010
35. Navare SM, Mather JF, Shaw LJ, et al: Comparison of risk stratification with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol 11:551-561, 2004 (Pubitemid 39341800)
36. Maddahi J, Bengel FM, Huang S, et al: Phase I rest-stress study of F-18 labeled BMS747158 myocardial perfusion PET tracer: human safety, dosimetry, biodistribution, and myocardial imaging characteristics. J Nucl Med 50:48p, 2009
37. Mistry M, Onthank D, Green J, et al: Toxicological evaluation of BMS-747158, a PET myocardial perfusion imaging agent. Toxicologist 102: 476, 2008
38. Yu M, Bozek J, Guaraldi M, et al: Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits. J Nucl Cardiol 17:631-636, 2010
39. Lazewatsky J, Azure M, Guaraldi M, et al: Dosimetry of BMS747158, a novel 18F labeled tracer for myocardial perfusion imaging, in nonhuman primates at rest. J Nucl Med 49:15p, 2009
40. Delbeke D, Coleman RE, Guiberteau MJ, et al: Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0. J Nucl Med 47:885-895, 2006 (Pubitemid 46768453)